Filing Details

Accession Number:
0001371285-20-000316
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-02 18:51:14
Reporting Period:
2020-11-30
Accepted Time:
2020-12-02 18:51:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1371285 Trupanion Inc. TRUP Hospital & Medical Service Plans (6324) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1622728 Asher Bearman C/O Trupanion, Inc.
6100 4Th Avenue S, Suite 200
Seattle WA 98108
Chief Strategy Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-11-30 2,345 $101.02 3,787 No 4 S Direct
Common Stock Disposition 2020-11-30 1,573 $98.72 2,214 No 4 S Direct
Common Stock Acquisiton 2020-11-30 12,655 $4.77 14,869 No 4 M Direct
Common Stock Disposition 2020-11-30 12,655 $100.53 2,214 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2020-11-30 12,655 $0.00 12,655 $4.77
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
67,162 2023-08-02 No 4 M Direct
Footnotes
  1. The sales reported were effected in order to allow the reporting person to enter into a real estate purchase.
  2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.00 to $101.065 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2).
  3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.665 to $99.15 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3).
  4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.84 to $101.48 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4).
  5. This stock option grant is fully vested.